DK0426098T3 - Fremstilling af et lægemiddel til behandling af hyperphosphatæmisk status - Google Patents

Fremstilling af et lægemiddel til behandling af hyperphosphatæmisk status

Info

Publication number
DK0426098T3
DK0426098T3 DK90120778.7T DK90120778T DK0426098T3 DK 0426098 T3 DK0426098 T3 DK 0426098T3 DK 90120778 T DK90120778 T DK 90120778T DK 0426098 T3 DK0426098 T3 DK 0426098T3
Authority
DK
Denmark
Prior art keywords
hyperphosphatemic
drug
status
preparation
treatment
Prior art date
Application number
DK90120778.7T
Other languages
Danish (da)
English (en)
Inventor
Norbert Dr Gretz
Eckhard Dr Zimmermann
Original Assignee
Bartz Volker
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6392624&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0426098(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bartz Volker filed Critical Bartz Volker
Application granted granted Critical
Publication of DK0426098T3 publication Critical patent/DK0426098T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Dental Preparations (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DK90120778.7T 1989-11-01 1990-10-30 Fremstilling af et lægemiddel til behandling af hyperphosphatæmisk status DK0426098T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3936319A DE3936319C3 (de) 1989-11-01 1989-11-01 Phosphatbinder zur oralen Verabreichung

Publications (1)

Publication Number Publication Date
DK0426098T3 true DK0426098T3 (da) 1994-10-31

Family

ID=6392624

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90120778.7T DK0426098T3 (da) 1989-11-01 1990-10-30 Fremstilling af et lægemiddel til behandling af hyperphosphatæmisk status

Country Status (7)

Country Link
EP (1) EP0426098B1 (enrdf_load_stackoverflow)
JP (1) JPH05501405A (enrdf_load_stackoverflow)
AT (1) ATE106724T1 (enrdf_load_stackoverflow)
DE (2) DE3936319C3 (enrdf_load_stackoverflow)
DK (1) DK0426098T3 (enrdf_load_stackoverflow)
ES (1) ES2055847T3 (enrdf_load_stackoverflow)
WO (1) WO1991006294A1 (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528524C2 (de) * 1995-08-03 1999-11-11 Hans Dietl Calciumhaltiges Mittel zur intestinalen Phosphatbindung und Verfahren zu seiner Herstellung
DE19917705C1 (de) * 1999-04-20 2000-12-28 Vitasyn Gmbh Mittel zur Therapie von Hyperphosphatämie
US6706287B2 (en) * 2001-05-15 2004-03-16 Kibow Biotech Inc. Prebiotic and probiotic compositions and methods for their use in gut-based therapies
ITME20040015A1 (it) 2004-12-07 2005-03-07 Vincenzo Savica Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1281411A (fr) * 1960-12-01 1962-01-12 Brion Ets Dispositif indicateur numérique pour la mesure de grandeurs électriques
DE2335215B2 (de) * 1972-07-13 1979-04-05 The Johns Hopkins University, Baltimore, Md. (V.St.A.) Verwendung einer Mischung bei der Bekämpfung von zur Urämie führenden Nierenerkrankungen
DE2516027A1 (de) * 1973-04-30 1975-10-16 Univ Johns Hopkins Arzneimittel zur foerderung der proteinsynthese und zur konservierung des stickstoffs im koerper
DE2531299A1 (de) * 1975-07-12 1977-01-13 Fresenius Chem Pharm Ind L-amino- und hydroxy- und/oder ketosaeuren enthaltende gemische fuer parenterale oder orale anwendung
US4296127A (en) * 1979-04-18 1981-10-20 The Johns Hopkins University Mixed salts of essential or semi-essential amino acids and nitrogen-free analogs thereof
DE3046580A1 (de) * 1980-12-11 1982-07-01 Leskovar, Peter, Dr.-Ing., 8000 München Harnsteinaufloesende mittel
US4491589A (en) * 1982-05-17 1985-01-01 The Trustees Of Columbia University In The City Of New York Amino acid solutions for parenteral nutrition and methods of formulation and use
JPS6136222A (ja) * 1984-07-26 1986-02-20 Chugai Pharmaceut Co Ltd 高リン酸血症治療剤
AU6777487A (en) * 1985-12-18 1987-07-15 Veech, R.L. Parenteral nutrition therapy with amino acids

Also Published As

Publication number Publication date
DE3936319C2 (enrdf_load_stackoverflow) 1991-11-21
DE59006025D1 (de) 1994-07-14
ES2055847T3 (es) 1994-09-01
WO1991006294A1 (de) 1991-05-16
DE3936319A1 (de) 1991-05-02
EP0426098B1 (de) 1994-06-08
ATE106724T1 (de) 1994-06-15
EP0426098A1 (de) 1991-05-08
JPH05501405A (ja) 1993-03-18
DE3936319C3 (de) 1997-05-07

Similar Documents

Publication Publication Date Title
ES550807A0 (es) Un procedimiento para la produccion de un preparado farmaceutico de liberacion lenta y controlada.
DK0509317T3 (da) Lægemidler imod knoglesygdomme
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
SE8504720L (sv) Ny lekemedelsberedning
UA19303A (uk) Спосіб одержаhhя похідhих 2-аhіліhопіримідиhу
ATE79252T1 (de) Zusammensetzung mit einem biologisch abbaubaren augenimplantat.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DE3586713D1 (de) Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
FI873363A0 (fi) Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet.
DE3750849D1 (de) Feste kalziumphosphat-materialien.
DE3679920D1 (de) Spiro-3-heteroazolidinverbindungen und ihre salze, ihre herstellung und diese enthaltende pharmazeutische mittel.
EP0357793A4 (en) Suspended-release preparation prepared by using alginic acid
DE3687541D1 (de) Verwendung von kalziumantagonisten zur anfertigung von zusammensetzungen fuer entziehungssymptome.
AU1876788A (en) Methylene phosphonoalkylphosphinates, pharmaceutical compositions , and methods for treating abnormal calcium and phosphate metabolism
BG46599A3 (en) Method for preparing of benzene azetonitriles
ES2032905T3 (es) Sistema terapeutico transcutaneo.
DE3875595D1 (de) Bolusfoermige vorrichtung zur gesteuerten wirkstofffreisetzung.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
DK0426098T3 (da) Fremstilling af et lægemiddel til behandling af hyperphosphatæmisk status
DK422488A (da) Arylpyrroler, fremgangsmaader til deres fremstilling samt deres anvendelse som insecticider, acaricider og nematodicider
DE3681856D1 (de) Pharmazeutische 2-oxopyrrolidinverbindungen, ihre salze und ihre herstellung.
ES2043719T3 (es) Administracion de farmacos por via percutanea.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE59005355D1 (de) Dialysier- und Spüllösung zur intraperitonealen Verarbreichung.
ES2019634B3 (es) Terapia con clorfeniramina.